Skip to content
★ Sign in to follow
SF

Stephen Farley Ross

CFO
Remedent, Inc.
Total declarations
7
Company
1
▲ Purchases (7 ops.)
€3,985
▼ Sales (0 ops.)
—

Latest filing published 28 Aug 2009 for REMEDENT, INC., €99.

Insider track record

Disclosed buys
7
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
7
Positive at T+90
17%
Median T+90
-23.1%

Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 28 Aug 2009 · 6281 days ago · €99
    -25.0%
    Entry 0.52 · Close at T+365 0.39
  • Filed 29 Dec 2008 · 6523 days ago · €574
    -44.3%
    Entry 0.70 · Close at T+365 0.39
  • Filed 19 Dec 2008 · 6533 days ago · €1,562
    +33.3%
    Entry 0.30 · Close at T+365 0.40

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Stephen Farley Ross: trading record in brief

Stephen Farley Ross appears in our data through filings on Remedent, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 17 December 2008 to 31 July 2009, the count stands at 7 filings.

Purchases make up the whole of the open-market record (7 purchases, €3,985). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2009: 4 purchases and no sales on the market.

Half of the purchases are above €106 and half below. For 6 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 17% of cases, with a median move of -23.1%. They describe history only and say nothing certain about the share price ahead.

Most recently, on 28 August 2009, the filings show an open-market purchase worth €99 in Remedent, Inc. Typically, a trade is published a median of 28 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Stephen Farley Ross

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ▲
    CFO; SecretaryExecutivesRemedent, Inc.
    135 USD0SEC
    150 shares@ US$0.90Common StockSEC:0001001277-09-000150:0
    Canonical exit: 10 Aug 2009 (T+90)
  • ▲
    CFO; SecretaryExecutivesRemedent, Inc.
    150 USD0SEC
    200 shares@ US$0.75Common StockSEC:0001001277-09-000150:1
    Canonical exit: 26 Aug 2009 (T+90)
  • ▲
    CFO; SecretaryExecutivesRemedent, Inc.
    65 USD0SEC
    100 shares@ US$0.65Common StockSEC:0001001277-09-000150:2
    Canonical exit: 14 Oct 2009 (T+90)
  • ▲
    CFO; SecretaryExecutivesRemedent, Inc.
    52 USD0SEC
    100 shares@ US$0.52Common StockSEC:0001001277-09-000150:3
    Canonical exit: 29 Oct 2009 (T+90)
  • ▲
    CFO; SecretaryExecutivesRemedent, Inc.
    800 USD0SEC
    2,000 shares@ US$0.40Common StockSEC:0001001277-08-000173:0
    Canonical exit: 23 Mar 2009 (T+90)
  • ▲
    CFO; SecretaryExecutivesRemedent, Inc.
    2,250 USD0SEC
    5,000 shares@ US$0.45Common StockSEC:0001001277-08-000165:0
    Canonical exit: 17 Mar 2009 (T+90)

6 of 6 declarations